Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)

1. Investigate the clinical characteristics, medication satisfaction and quality of life of anti-hypertensive drugs in Korean hypertensive patients 2. Observe the changes of medication satisfaction and compliance in patients after switchting to Fimasartan

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Behavior Cardiovascular Diseases Health Behavior Medication Adherence Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance Vascular Diseases

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Korea university Guro hospital

Seoul, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Step1

Over 20 years old
Essential hypertensive patients who taking anti-hypertensive drugs during previous 1 month

Step2

Patients does not taking Fimasartan
Patient's medication satisfaction score under 4

Exclusion criteria

Patients with secondary hypertension
Patients with orthostatic hypotension who has sign and symptom
Patients with known severe or malignancy retinopathy
Patients with significant investigations; abnormal renal function
Childbearing and breast-feeding women
Patients with history of allergic reaction to any angiotensin II antagonist

Treatment and study plan

Primary outcomes

quality of life questionnaire for hypertension

Time frame: up to 1 month
medication satisfaction questionnaire

Time frame: up to 8 weeks

Secondary outcomes

Drug compliance questionnaire

Time frame: up to 8 weeks

Sponsors and collaborators

Lead sponsor

Boryung Pharmaceutical Co., Ltd

Industry

Registry information

Official study title

Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient: a Prospective, Cross-sectional and Open-label 8 Week Switching Study

Acronym: K-HEMS

Important dates

Study start: 2014
Primary completion: 2015
Study completion: 2015
First posted: Mar 20, 2015
Registry last updated: Jul 11, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed